Propecia pricing, prescription access, and savings guidance - in Australia

Macro view

Product name: Propecia (commonly used name). Active drug: finasteride.

Primary clinical use: treatment of male pattern hair loss (androgenetic alopecia). A higher strength formulation of finasteride is also prescribed for benign prostatic hyperplasia (BPH).

Common available tablet strengths: 1 mg (typical dose for hair loss) and 5 mg (usually used for prostate enlargement).

What to expect: Clinical trials and real-world use show improved hair density at the vertex and slowed frontal hairline retreat for many users. Noticeable benefit commonly requires continuous daily therapy for at least 3 to 6 months. When treatment stops, any gains tend to be lost over several months.

To know how to take notes the medicine, read the number one spotic instruction booklet. Dose schedule and directions and cautions and administration instructions. For safety concerns, jump to Safety preventive actions and safety requirements.

This course is for whom

• Adult men: finasteride is indicated for adult male patients for androgenetic hair loss.
• Not recommended for: women of childbearing potential, pregnant women, and children.
• Other indication: the 5 mg formulation is commonly used for BPH; finasteride is not a treatment for prostate cancer.

Dosing notes and directions

• For hair loss: take 1 mg by mouth once daily. It can be taken either with meals or on an empty stomach.
• For BPH: the usual dose is 5 mg by mouth once a day, with or without food, as prescribed by a clinician.
• Administration points:
  • Swallow whole with water; do not crush, break, or chew tablets.
  • If a tablet is broken or crushed, pregnant women should avoid handling the powder because of potential risk to a male fetus.
  • Try to take the tablet at the same time each day to improve adherence.
• Always follow the dosing and duration advised by your prescriber. Do not alter the dose without medical advice.

More references Skipped dose and Overdose occurrence advice on safety for additional instructions.

Safety measures for safety

• Allergy information: inform your doctor or pharmacist if you have known allergy to finasteride, dutasteride, or any tablet ingredients.
• Pregnancy risk: finasteride is contraindicated in pregnancy. Women who are or may become pregnant must not handle crushed or broken tablets.
• Mental health: rare reports of mood changes, depression, and suicidal ideation exist. Seek urgent medical help if you experience new or worsening mood symptoms.
• Breast and endocrine signs: report any breast pain, lumps, or nipple discharge to your healthcare provider.
• Prostate screening: finasteride reduces prostate specific antigen (PSA) levels by around half. Tell clinicians you are taking finasteride before PSA testing.
• Liver disease: use cautiously in patients with significant hepatic impairment; surveillance of system activity may be required.
• Blood donation: avoid donating blood while on treatment and for at least one month after stopping to prevent exposing a pregnant transfusion recipient.
• Driving and machinery: dizziness and visual disturbance can occur; if affected, avoid driving or using heavy machinery.

If a condition completely prevents use of finasteride, see Not indicated conditions.

Conditions precluding use

• Known allergic reaction to finasteride or to 5-alpha-reductase inhibitors such as dutasteride.
• Women who are pregnant or may become pregnant, and children.

Potential systemic undesired reactions

Most users tolerate finasteride, but adverse health effects can occur. Many effects are reversible on stopping the medication.

• Repeating effects: decreased sexual desire, erectile difficulties, lower ejaculate volume, tiredness, sleep problems, dizziness, nasal congestion, or blurred vision.
• Not commonly found: testicular discomfort, breast tenderness or enlargement, skin reactions such as rash or itching.
• Serious signs requiring immediate medical attention: new onset depression or suicidal thoughts, breast lumps or nipple discharge, or signs of a severe allergic reaction like facial swelling or wheeze.

Report any unexpected symptoms to your doctor or pharmacist. For safety topicsthe review cycle Hazard mitigation steps and risk controls.

Therapeutic pharmacokinetic and pharmacodynamic the interaction between participantss create opportunities for collaboration. between drugs

• Provide a full list of prescription, over-the-counter medicines, and supplements to your prescriber or pharmacist before starting finasteride.
• Please please do not combine these items.. finasteride with other 5-alpha-reductase inhibitors (for example, dutasteride) unless specifically advised.
• Herbal products such as saw palmetto have overlapping hormonal effects; discuss these in meeting with your clinician.
• Laboratory tests: remember that finasteride lowers PSA results; inform the laboratory and your clinician.

Overall, finasteride has relatively few major drug-tracking the dynamics of interactions helps measure engagement. caused by drugs, but checking each patient's medicines is recommended.

Medication dose missed

If you miss a single dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed tablet and continue the regular schedule. Do not attempt to make up a the dose was missed by taking two doses together.

Australia specific urgent to overdose assistance information

Serious a drug overdose case is unlikely from single extra tablets, but medical advice is still sensible.

• Possible symptoms of consuming an overdose: nausea, fainting, dizziness, chest discomfort, or palpitations.
• In Australia: for immediate advice call the Poisons Information Centre on 13 11 26. In the event of a life-threatening emergency, dial 000 now.

Storage module

• Keep it at standard room temperature, ideally 20 to 25 C (68 to 77 F).
• Store tablets in their original packaging, protected from moisture and direct light.
• Do not keep in bathrooms. Keep this out of sight and reach of children and pets.
• Return unused or expired medication to a pharmacy for safe disposal when possible.

Prices for Australia (AUD)

Actual retail cost varies by brand, pharmacy, and whether the Pharmaceutical Benefits Scheme (PBS) applies. The amounts below are indicative for a one month supply.

• Finasteride 1 mg (for hair loss, usually not PBS-subsidised): generic tablets often cost about AUD 15 to 40 per month; the Propecia brand commonly ranges AUD 50 to 90.
• Finasteride 5 mg (for BPH, frequently PBS-subsidised for eligible patients): patient co-pay or generic retail price may be around AUD 8 to 20 depending on PBS status and concession entitlements.
• Compounded topical finasteride or specialised formulations tend to be more expensive and are rarely PBS-subsidised; prices vary widely by compounding pharmacy.

Compare before deciding local pharmacy prices and ask your prescriber about PBS eligibility or generic alternate options to reduce cost.

Different medicines and related formulations

If finasteride is unsuitable or you are exploring various other treatments, discuss these common options with your clinician:

• Topical minoxidil (2 percent or 5 percent solutions or foams): available as an over-the-counter medicine in many pharmacy outlets. Typical price range is around AUD 15 to 35 per 60 mL depending on brand and strength.
• Dutasteride 0.5 mg: another 5-alpha-reductase inhibitor. It is prescription-only (S4) and sometimes used off-label for hair loss; generic monthly cost is commonly AUD 15 to 40 when purchased privately.
• Topical finasteride preparations: compounded products are prescribed in some clinics; strengths and prices vary and long-term safety evidence is limited.
• For BPH specifically:
  • Alpha-blockers such as tamsulosin or alfuzosin to improve urinary symptoms. Generic options often cost about AUD 10 to 30 per month and many are PBS-listed.
  • Combination therapy (finasteride plus an alpha-blocker) or dutasteride options are chosen based on prostate size and symptoms.
  • Non-drug options include lifestyle changes and surgical interventions for severe cases.
• Nonpharmacologic varied options for hair loss: hair transplant surgery, low-level laser therapy, and cosmetic approaches. Costs and effectiveness vary greatly.

Selection depends on diagnosis, side effect profile, personal preference, and cost. See Safety and risk hazard controls and Potential adverse reactions to reinforce safety.

The status of lawful authorization recognized in Australia

• Regulatory classification: finasteride in all strengths is Schedule 4 - Prescription Only Medicine on the Australian mainland.
• How to obtain: a valid prescription from an Australian registered prescriber is required. Community and hospital pharmacies dispense the medicine, including scripts issued via telehealth.
• PBS details:
  • Finasteride 5 mg for BPH is commonly listed on the PBS for eligible patients under specified criteria.
  • Finasteride 1 mg for hair loss is generally not PBS-subsidised and is typically paid for privately.
• Personal importation: under the TGA Personal Importation Arrangement you may import a limited supply for personal use if you hold a valid prescription. Check Customs and TGA guidance before importing.
• Advertising: promotional material for prescription medicines is restricted by Australian law and direct-to-consumer adverts are controlled.
• Handling protective actions: due to potential fetal risk, pregnant women should not handle crushed tablets.